Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|66|11|3160-3169

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.66, Iss.11, 2014-11, pp. : 3160-3169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3486-3495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 3, 2018-03 ,pp. : 349-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Macrophage Activation Syndrome in Children with Systemic-Onset Juvenile Chronic Arthritis

By  

Acta Haematologica, Vol. 113, Iss. 2, 2005-03 ,pp. : 124-129

Karger

Access to resources Recommend Favorite

Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1034-1043

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Systemic‐Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2645-2645

John Wiley & Sons Inc

Access to resources Recommend Favorite